Coverage from:
ESMO 2024 2024
Analysis of new data presented at the European Society for Medical Oncology (ESMO) annual meeting 2024, delivered by an expert faculty in the field of oncology.
This content has been developed independently by Touch Medical Media for touchONCOLOGY in conjunction with expert faculty. This content is not affiliated with ESMO 2024.
Topics Covered:
Bladder Cancer
Breast Cancer
Gastrointestinal Cancers
Genitourinary Cancer
+ More
Highlighted Content
Transarterial chemoembolization with lenvatinib and pembrolizumab showed improvement in progression-free survival for hepatocellular carcinoma
Watch Now